Subscribe to Search results

A new version of Scottish Government Records Management: Health and Social Care Code of Practice was issued.

Published on:

A Northern Ireland Hospital Authority Circular provided that records be retained 6 years after the conclusion of treatment and 3 years after the patient's death if they died in hospital.

Published on:

A circular relating to the Retention of Personal Health Records (For Possible Use in Litigation) issued by the Department of Health and Social Services in Northern Ireland provided records be retained 8 years after the death of a patient or conclusion of treatment.

Published on:

A circular relating to the Retention of Personal Health Records (For Possible Use in Litigation) issued by the Health and Social Services Directorate in Northern Ireland provided records be retained 8 years after the last entry.

Published on:

In a letter to Dr Rosemary Biggs, Dr Cumming noted that there was no valid reason for a shortage of "coagulation factor" products, and that recent results from frozen plasma used in the production of concentrate meant that cryoprecipitate use would decline as centralised production by other methods was feasible.

Published on:

A product information sheet for the Scottish achievement recorded that it had ten times as much Factor 8 activity as fresh frozen plasma, and that "A similar fraction is prepared by ether fractionation (Kekwick)."

Published on:

An article "Red Cell Banking and the Production of a Factor VIII Concentrate" published in Vox Sanguinis demonstrated that by 1960, the Blood Products Unit in Edinburgh was fractionating plasma from 1,425 donors and investigating red cell concentrates to make full use of the donated blood.

Published on:

An article titled "A Concentrate of Human Antihaemophilic Factor - its use in six cases of haemophilia" published in The Lancet reported that they had developed antihaemophilic fraction ("AHF") which would enable clotting and had been used with success in six cases.

Published on:

In an article on "The Use of Human Anti-haemophilic Globulin (Fraction I-O) in Haemophilia A and in von Willebrand's Disease" published in Acta Haematologica, the development of antihaemophilic globulins (AHG) was reported which had treated 59 patients by 1959 in Sweden.

Published on:

The minutes of the meeting of the Joint Steering Committee on Blood Products Production recorded that planning to extend BPL had commenced in 1962, however building had only commenced in 1969. The extension of BPL had operated at capacity from April 1972, and the original buildings were also being modernised with the expectation they would be completed by August 1973.

Published on:

A letter from the SHHD to Dr Maycock addressed the question of how much plasma the Blood Products Unit in Edinburgh would fractionate for England and Wales.

Published on:

Dr Gunson and Dr Helen Dodsworth wrote "Fifty Years of Blood Transfusion" published in Transfusion Medicine which outlined the history of transfusion medicine in England and Wales.

Published on:

PFC first produced factor concentrates in January 1975, and reached full capability using "9 to 5" production in 1976.

Published on:

The Immuno Limited Table of Supply for Kryobulin and Bebulin 1969-1972 showed that Kryobulin was first used in the UK in 1970.

Published on:

Dr Biggs wrote to Professor Edward Blackburn regarding the problem of coming up with a 10-year estimate of how much blood would need to be collected in the UK. The subjectivity of clinical need, as well as the difference between "demand" and "need" for treatments meant that it was not easy to identify.

Published on:

A memo from Donald Jackson to Michael Lillywhite (DHSS) illustrated the difficulty of of providing an estimate for the level for production which would achieve self-sufficiency.

Published on:

John Watt wrote to Dr Rosemary Biggs expressing that one standard view at the time was that people with haemophilia needed to be able to live a normal sedentary lifestyle.

Published on:

There was always self-sufficiency in blood. London private hospitals would source blood from abroad and when they were over-provided, they would then pass their surplus to the NHS. Some patients in London would be given blood which was not necessarily tested in the same way as NHS blood would have been nor sourced from voluntary donors.

Published on:

Malcolm Widdup wrote to Andrew Mitchell to say more AHF/AHG was needed and Dr Bigg's view was convincing enough that the Treasury were prepared to fund preparations to meet it.

Published on:

England had a number of reference centres with haemophilia centres within their area. Oxford was the reference centre for the Alton Centre which served Treloar's school.

Published on: